Personalis Inc (NASDAQ: PSNL) on Tuesday, soared 12.80% from the previous trading day, before settling in for the closing price of $5.00. Within the past 52 weeks, PSNL’s price has moved between $0.89 and $7.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 18.20%. The company achieved an average annual earnings per share of 45.48%. With a float of $31.59 million, this company’s outstanding shares have now reached $50.48 million.
Let’s determine the extent of company efficiency that accounts for 225 employees. In terms of profitability, gross margin is 27.76%, operating margin of -108.09%, and the pretax margin is -101.73%.
Personalis Inc (PSNL) Insider Activity
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Personalis Inc is 40.48%, while institutional ownership is 50.18%. The most recent insider transaction that took place on Nov 01 ’24, was worth 142,263. In this transaction PRESIDENT AND CEO of this company sold 26,443 shares at a rate of $5.38, taking the stock ownership to the 178,098 shares. Before that another transaction happened on Aug 16 ’24, when Company’s 10% Owner bought 3,500,000 for $5.07, making the entire transaction worth $17,745,000. This insider now owns 12,718,800 shares in total.
Personalis Inc (PSNL) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 45.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -13.70% during the next five years compared to -28.46% drop over the previous five years of trading.
Personalis Inc (NASDAQ: PSNL) Trading Performance Indicators
Personalis Inc (PSNL) is currently performing well based on its current performance indicators. A quick ratio of 3.05 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.63, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Personalis Inc (PSNL)
Looking closely at Personalis Inc (NASDAQ: PSNL), its last 5-days average volume was 0.77 million, which is a jump from its year-to-date volume of 0.71 million. As of the previous 9 days, the stock’s Stochastic %D was 65.09%. Additionally, its Average True Range was 0.38.
During the past 100 days, Personalis Inc’s (PSNL) raw stochastic average was set at 74.28%, which indicates a significant decrease from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.51% in the past 14 days, which was lower than the 142.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.18, while its 200-day Moving Average is $2.73. However, in the short run, Personalis Inc’s stock first resistance to watch stands at $5.86. Second resistance stands at $6.09. The third major resistance level sits at $6.53. If the price goes on to break the first support level at $5.19, it is likely to go to the next support level at $4.75. Should the price break the second support level, the third support level stands at $4.52.
Personalis Inc (NASDAQ: PSNL) Key Stats
Market capitalization of the company is 299.34 million based on 53,075K outstanding shares. Right now, sales total 73,480 K and income totals -108,300 K. The company made 22,580 K in profit during its latest quarter, and -12,800 K in sales during its previous quarter.